SBIR Phase II: High-Performance and Green Materials Based on Engineered Cellulose-Producing Bacteria

SBIR第二阶段:基于工程纤维素生产细菌的高性能绿色材料

基本信息

  • 批准号:
    2310226
  • 负责人:
  • 金额:
    $ 100万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Cooperative Agreement
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

The broader/commercial impact of this Small Business Innovation Research (SBIR) Phase II project is the reduction of greenhouse gas (GHG) emissions by replacing plastics with cellulose secreted by genetically modified bacteria in the form of synthetic leather. This substitution effort will assist the USA in reaching net-zero GHG emissions by saving over 660 million metric tons of carbon dioxide (CO2) or CO2-equivalent gases by 2050. Replacing synthetic leathers made from polyvinyl chloride (PVC) polyurethane (PU) or hide-based leather with bacterial cellulose will have significant environmental benefits. Being petroleum-based, PVC and PU production has significant GHG emissions. Genuine leather requires transport of hides to tanneries, most of which are no longer located in the USA. Additionally, the water-intensive tanning and dyeing processes produce toxic wastes. In contrast, growth and processing of bacterial cellulose produces little to no toxic waste and few GHG emissions. Further, the material is biodegradable (unlike PVC or PU), which is appealing to consumers in the rapidly growing market for vegan leather. Scale-up of the production to replace plastics worldwide with this sustainable material will reduce trash generation and alleviate the problem of plastic waste in the environment. This Small Business Innovation Research (SBIR) Phase II project will enhance the properties of the existing synthetic leather materials and will develop the technology to produce large quantities of the material at low cost. Composed of bacterial cellulose, this high-performance, environmentally friendly material will impact the textile, construction, and packaging industries. The material looks, feels, and performs like real leather having desirable properties such as suppleness, sew-ability, and high tensile strength. The initial focus will be on creating a vegan leather alternative consisting of multiple cellulose sheets combined using a proprietary formulation. This project will enable the refinement of the material to meet industry standards for durability (e.g., water resistance, flex resistance, abrasion resistance, colorfastness) and aesthetics (color and patterns) and will develop the processes for producing the material at a commercial scale to meet market demand for quantity and price. Further, the fast-growing bacterial strains provide a competitive advantage for scale-up. The research will provide a solid scientific foundation to produce much larger quantities of this cellulose-based material at competitive prices for other applications such as insulation for the construction industry.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
这一小型企业创新研究(SBIR)第二阶段项目的更广泛/商业影响是通过用转基因细菌以合成皮革形式分泌的纤维素替代塑料来减少温室气体(GHG)排放。这一替代努力将有助于美国实现温室气体净零排放,到2050年将节省6.6亿吨二氧化碳或二氧化碳当量气体。用细菌纤维素取代由聚氯乙烯(PVC)、聚氨酯(PU)或生皮制成的合成革将具有显著的环境效益。由于以石油为基础,PVC和PU生产产生大量温室气体排放。真正的皮革需要将皮革运输到制革厂,其中大部分不再位于美国。 此外,水密集的制革和染色过程产生有毒废物。相比之下,细菌纤维素的生长和加工几乎不产生有毒废物和温室气体排放。此外,该材料是可生物降解的(不像PVC或PU),这对快速增长的纯素皮革市场的消费者很有吸引力。扩大生产规模,在全球范围内用这种可持续材料取代塑料,将减少垃圾的产生,缓解环境中的塑料废物问题。该小型企业创新研究(SBIR)第二阶段项目将提高现有合成革材料的性能,并将开发以低成本生产大量材料的技术。由细菌纤维素组成,这种高性能,环保的材料将影响纺织,建筑和包装行业。该材料看起来、感觉上和性能上像真实的皮革,具有所需的性能,例如柔软性、可缝合性和高拉伸强度。最初的重点将是创造一个素食皮革替代品,由多个纤维素片结合使用专有配方。该项目将使材料得到改进,以满足耐用性的行业标准(例如,耐水性、耐弯曲性、耐磨性、色牢度)和美观性(颜色和图案),并将开发以商业规模生产材料的工艺,以满足市场对数量和价格的需求。此外,快速生长的细菌菌株提供了扩大规模的竞争优势。该研究将为以具有竞争力的价格生产更大数量的这种纤维素基材料提供坚实的科学基础,用于其他应用,如建筑行业的绝缘材料。该奖项反映了NSF的法定使命,并通过使用基金会的知识价值和更广泛的影响审查标准进行评估,被认为值得支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lina Gonzalez其他文献

Cost–utility analysis of the DREAMS START intervention for people living with dementia and their carers: a within-trial economic evaluation
针对痴呆症患者及其照顾者的 DREAMS START 干预措施的成本-效用分析:一项试验内的经济评估
  • DOI:
    10.1016/j.lanhl.2025.100708
  • 发表时间:
    2025-05-01
  • 期刊:
  • 影响因子:
    14.600
  • 作者:
    Lina Gonzalez;Penny Rapaport;Gill Livingston;Sarah Amador;Mariam O Adeleke;Julie A Barber;Sube Banerjee;Georgina Charlesworth;Chris Clarke;Colin A Espie;Simon D Kyle;Malgorzata Raczek;Zuzana Walker;Lucy Webster;Monica Manela;Rachael Maree Hunter
  • 通讯作者:
    Rachael Maree Hunter
Clinical effectiveness of DREAMS START (Dementia Related Manual for Sleep; Strategies for Relatives) versus usual care for people with dementia and their carers: a single-masked, phase 3, parallel-arm, superiority randomised controlled trial
DREAMS START(与睡眠相关的痴呆症手册;亲属策略)与针对痴呆症患者及其护理人员的常规护理相比的临床有效性:一项单盲、3 期、平行组、优效性随机对照试验
  • DOI:
    10.1016/j.lanhl.2024.08.004
  • 发表时间:
    2024-10-01
  • 期刊:
  • 影响因子:
    14.600
  • 作者:
    Penny Rapaport;Sarah Amador;Mariam O Adeleke;Julie A Barber;Sube Banerjee;Georgina Charlesworth;Chris Clarke;Colin A Espie;Lina Gonzalez;Rossana Horsley;Rachael Hunter;Simon D Kyle;Monica Manela;Malgorzata Raczek;Zuzana Walker;Lucy Webster;Hang Yuan;Gill Livingston
  • 通讯作者:
    Gill Livingston
Clinical effectiveness of drop-in mental health services in paediatric healthcare settings: a non-randomised multi-site study for children, young people and their families
  • DOI:
    10.1186/s12913-025-12681-1
  • 发表时间:
    2025-04-14
  • 期刊:
  • 影响因子:
    3.000
  • 作者:
    Anna Roach;Sophie Bennett;Isobel Heyman;Anna Coughtrey;Neha Batura;Lina Gonzalez;Nicki Astle;Rebekah Coates;Jessie Drinkwater;Rebecca Evans;Una Frederick;Michael Groszmann;Steve Jones;Katie McDonnell;Sarah Marley;Amanda Mobley;Abbie Murray;Helena O’Sullivan;Sarah Ormrod;Nyah Patel;Theo Prendegast;Usha Rajalingam;Venkat Reddy;Ameenat Lola Solebo;Isabella Stokes;Emily Webster;Rebecca Webster;Gareth Vinton;Roz Shafran
  • 通讯作者:
    Roz Shafran

Lina Gonzalez的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lina Gonzalez', 18)}}的其他基金

SBIR Phase I: Aerogels Derived from Genetically Engineered Microbial Cells
SBIR 第一阶段:源自基因工程微生物细胞的气凝胶
  • 批准号:
    2050101
  • 财政年份:
    2021
  • 资助金额:
    $ 100万
  • 项目类别:
    Standard Grant

相似国自然基金

Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark Supercooled Phase Transition
  • 批准号:
    24ZR1429700
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
ATLAS实验探测器Phase 2升级
  • 批准号:
    11961141014
  • 批准年份:
    2019
  • 资助金额:
    3350 万元
  • 项目类别:
    国际(地区)合作与交流项目
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
  • 批准号:
    41802035
  • 批准年份:
    2018
  • 资助金额:
    12.0 万元
  • 项目类别:
    青年科学基金项目
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究
  • 批准号:
    61675216
  • 批准年份:
    2016
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
基于Phase-type分布的多状态系统可靠性模型研究
  • 批准号:
    71501183
  • 批准年份:
    2015
  • 资助金额:
    17.4 万元
  • 项目类别:
    青年科学基金项目
纳米(I-Phase+α-Mg)准共晶的临界半固态形成条件及生长机制
  • 批准号:
    51201142
  • 批准年份:
    2012
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
连续Phase-Type分布数据拟合方法及其应用研究
  • 批准号:
    11101428
  • 批准年份:
    2011
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
D-Phase准晶体的电子行为各向异性的研究
  • 批准号:
    19374069
  • 批准年份:
    1993
  • 资助金额:
    6.4 万元
  • 项目类别:
    面上项目

相似海外基金

SBIR Phase II: Innovative Glass Inspection for Advanced Semiconductor Packaging
SBIR 第二阶段:先进半导体封装的创新玻璃检测
  • 批准号:
    2335175
  • 财政年份:
    2024
  • 资助金额:
    $ 100万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: Intelligent Language Learning Environment
SBIR第二阶段:智能语言学习环境
  • 批准号:
    2335265
  • 财政年份:
    2024
  • 资助金额:
    $ 100万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: FlashPCB Service Commercialization and AI Component Package Identification
SBIR第二阶段:FlashPCB服务商业化和AI组件封装识别
  • 批准号:
    2335464
  • 财政年份:
    2024
  • 资助金额:
    $ 100万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: Thermally-optimized power amplifiers for next-generation telecommunication and radar
SBIR 第二阶段:用于下一代电信和雷达的热优化功率放大器
  • 批准号:
    2335504
  • 财政年份:
    2024
  • 资助金额:
    $ 100万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: Innovative Two-Phase Cooling with Micro Closed Loop Pulsating Heat Pipes for High Power Density Electronics
SBIR 第二阶段:用于高功率密度电子产品的创新两相冷却微闭环脉动热管
  • 批准号:
    2321862
  • 财政年份:
    2024
  • 资助金额:
    $ 100万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: Sodium-Based Solid-State Batteries for Stationary Energy Storage
SBIR第二阶段:用于固定储能的钠基固态电池
  • 批准号:
    2331724
  • 财政年份:
    2024
  • 资助金额:
    $ 100万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: A mesh-free, sling-free, minimally invasive treatment for stress urinary incontinence in women
SBIR II 期:无网、无吊带的微创治疗女性压力性尿失禁
  • 批准号:
    2233106
  • 财政年份:
    2024
  • 资助金额:
    $ 100万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: Zero Trust Solution for Precision Medicine and Precision Health Data Exchanges
SBIR 第二阶段:精准医疗和精准健康数据交换的零信任解决方案
  • 批准号:
    2226026
  • 财政年份:
    2024
  • 资助金额:
    $ 100万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: Computer-based co-reading for students with reading disabilities
SBIR 第二阶段:为有阅读障碍的学生提供基于计算机的共同阅读
  • 批准号:
    2321439
  • 财政年份:
    2024
  • 资助金额:
    $ 100万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: Development of a Novel Measurement Technology to Enable Longitudinal Multiomic Investigations of the Gut Microbiome
SBIR 第二阶段:开发新型测量技术以实现肠道微生物组的纵向多组学研究
  • 批准号:
    2314685
  • 财政年份:
    2024
  • 资助金额:
    $ 100万
  • 项目类别:
    Cooperative Agreement
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了